GlassScriptPhysician profile
Peter T Nassar
NPI 1669498622
$935.10
in general payments reported to CMS, 2019-2025
19 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.26 · 2020: $109 · 2021: $69.03 · 2022: $199 · 2023: $159 · 2024: $92.30 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $142.73 | 2023-2025 | |
| Abbott Laboratories | $109.35 | 2025 | Triclip |
| Itamar Medical INC | $79.38 | 2022 | |
| Amag Pharmaceuticals, INC. | $75.93 | 2019-2020 | |
| Hologic Sales and Service, LLC | $74.80 | 2023-2025 | Thinprep 2000 Processor, Acessa Provu System, Aptima |
| Therapeuticsmd, INC. | $72.75 | 2020-2022 | |
| Bard Access Systems, INC. | $52.32 | 2019 | |
| Sumitomo Pharma America, INC. | $47.65 | 2023-2025 | Myfembree |
| Ethicon US, LLC | $42.67 | 2022 | |
| Myovant Sciences INC. | $40.07 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $37.83 | 2023 | Exparel |
| Pfizer INC. | $32.85 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.25 | 2025 | |
| Lupin INC. | $22.96 | 2020 | |
| Shield Therapeutics INC | $17.97 | 2023 | Accrufer |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $17.06 | 2019 | |
| Sage Therapeutics, LLC | $15.93 | 2024 | |
| Evofem Biosciences, INC. | $14.67 | 2022 | |
| Boston Scientific Corporation | $11.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Nassar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.